Data & AI

All resources

Filter by:
Moving Beyond Claims-Led Targeting

Moving Beyond Claims-Led Targeting Guide
Data & AI HCP Engagement & Activation
Join us at Pharma Customer Engagement USA 2026

Turn diagnostic results into timely, targeted HCP engagement. Join Us at Pharma Customer Engagement USA 2026

 
HCP Engagement & Activation Data & AI
Smart Engagement Starts with Smart Data: Using AI in healthcare marketing to Reach the Right Physicians

AI could be worth billions to pharma commercial teams, but only if it targets physicians when it matters. Find out why traditional segmentation falls short, and how Physician Engage uses real-time diagnostic triggers to reach treating physicians within 24 hours and put patients at the centre.
By Scott Phillips
Data & AI
AnalyticsIQ and Diaceutics Partner to Launch Breakthrough Healthcare Audience Targeting

What if you could target HCPs by who they are, not just what they treat? Discover how Diaceutics and AnalyticsIQ are combining clinical and behavioral data in 80+ new healthcare audiences, available now in DeepIntent and Doceree.
By Sarah Heming
Data & AI
Diaceutics x Doceree Partnership: Power Precision HCP Targeting with Real-Time Diagnostic and Genomic Data

Claims data shows what happened months ago. Find out how Diaceutics' diagnostic and genomic audiences, now live in the Doceree Marketplace, help marketers reach treating physicians in real time with more than 100 pre-built segments.
By Sarah Heming
Data & AI
Diaceutics and IQM Redefine HCP Marketing with Real-Time, AI-Powered Diagnostic Audiences

Healthcare marketing is moving beyond months-old claims data. Discover how Diaceutics and IQM are making real-time, diagnostic-informed HCP audiences available at programmatic speed, with pharmaceutical-grade compliance.
By Sarah Heming
Data & AI
5 key highlights from Fierce Pharma Week 2026

Explore 5 key highlights from Fierce Pharma Week 2026, including timely HCP engagement, commercial applications of AI, omnichannel pharma marketing and patient engagement.

By Diaceutics Team
Data & AI HCP Engagement & Activation Commercial Strategy Optimization
Precision for All: Watch the New Diaceutics Manifesto

Diaceutics empowers biopharma to enhance patient outcomes by providing data-driven solutions for diagnostic-driven therapies. Ensuring every eligible patient receives timely and  effective treatment.

By Sarah Heming
Commercial Strategy Optimization HCP Engagement & Activation Data & AI
Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

By Sarah Heming
Data & AI
AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

By Gosia Leitch
Data & AI
ASCO 2026 Trends to Watch: Precision Oncology, AI and Real-World Impact

Explore key trends in precision oncology, AI integration, and real-world impact at ASCO 2026, focusing on biomarker-driven therapies and actionable insights for improved patient outcomes.

By Sarah Heming
Data & AI
Episode 8 The Pathology-Oncology Connection: Labs in Action

Explore how tailored testing and collaboration between labs and oncologists enhance diagnostic and treatment decisions in cancer care on the Better Testing, Better Treatment podcast.

Data & AI
Episode 7 Exploring Inherited Cancer: from clinic to lab

Discover how genetic testing for inherited cancer has evolved, transforming clinical practice and patient care, in episode 7 of the Better Testing, Better Treatment podcast.

Data & AI
Episode 6 Artificial Intelligence in Prostate Cancer: from clinic to lab

Discover how AI enhances prostate cancer diagnostics and treatment in our podcast featuring experts Pr. Sophie Ferlicot and Dr. Mario Terlizzi.

Data & AI
Episode 5 Oncogenic Fusion detection and reporting in NSCLC and solid tumors

Explore the latest insights on oncogenic fusion detection and reporting in NSCLC and solid tumors from experts Dr. Solomon and Dr. Saxena in this informative podcast episode.

Data & AI
Episode 4: Targeted therapies in cancer: From clinic to labs

Explore targeted cancer therapies from a European perspective in Episode 4 of the Better Testing, Better Treatment podcast, featuring insights from leading experts in the field.

Data & AI
Episode 3: Targeted therapies in Gastric cancer: From clinic to labs  

Explore targeted therapies in gastric cancer through insights from a pathologist and oncologist in this episode of the Better Testing, Better Treatment podcast series.

Data & AI
Data-driven targeting in HCP education: Engaging physicians within the critical treatment decision

Engage healthcare professionals effectively with data-driven strategies that enhance treatment decisions and improve patient outcomes in this informative online webinar.

HCP Engagement & Activation Data & AI
Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

By Scott Phillips
Data & AI
Complexity to Clarity: Using Multi-Modal Data to drive commercial success

Watch our webinar to explore how a multi-modal data approach can simplify complexities in precision medicine and enhance commercialization strategies for better patient outcomes.

Data & AI
Current and anticipated future use of MRD in hematological and solid tumors​

This report explores the current and future use of minimal residual disease (MRD) testing, uncovering adoption trends, clinical applications, and commercial implications.

 
Data & AI Regulatory Insights

Stay ahead with the diaceutics newsletter

Diagnostic-driven therapies are reshaping commercialization. Get evidence-based content, expert perspectives, and practical intelligence delivered straight to your inbox, every two weeks.

Ready to do commercialization differently?

Every patient journey contains opportunities to improve testing, engagement, and adoption. We can help you find them so more people get the right therapy sooner.